# K122882: Nmi Hpicc Iii

- Pathway: 510(k) (Special)
- Applicant: Navilyst Medical, Inc.
- Decided: Oct 18, 2012 after 28 days
- Product code: LJS (Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5970
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K001901 (2000). 43 ancestors in all.
12 later devices descend from it; 2 cite it directly.
2 of 56 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K121089: Nmi Picc Iii, Navilyst Medical, Inc. (2012) Summary page 1.
- K111906: Xcela Hybrid Picc with Pasv Valve Technology, Navilyst Medical, Inc. (2011) Summary page 1.

## Most influential descendants
- K131942: Nmi Picc Iii Catheter, Nmi Hpicc Iii Catheter (2013), 7 descendants of its own
- K133264: Nmi Picc Iii (2013), 6 descendants of its own
- K140266: Nmi Picc IV (2014), 3 descendants of its own
- K131038: Nmi Picc Maximal Barrier Nursing Kits (2013), 3 descendants of its own
- K142616: PICC Maximal Barrier Nursing Kit (2014), 2 descendants of its own

## Indications for use
The NMI HPICC III is indicated for short- or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients, the sampling of blood, and for power injection of contrast media. Non-valved lumens are indicated for central venous pressure monitoring. The maximum power injection flow rate for the NMI HPICC III is 6 mL/sec.

Source page: https://510kreport.com/device/K122882
Methodology: https://510kreport.com/methodology